OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials
Carmine Izzo, Monica Annunziata, Giuseppe Melara, et al.
Nutrients (2021) Vol. 13, Iss. 3, pp. 933-933
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Resveratrol (RV): A pharmacological review and call for further research
Lixue Zhang, Changxing Li, Mohib Ullah Kakar, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112164-112164
Open Access | Times Cited: 322

Resveratrol as a Promising Nutraceutical: Implications in Gut Microbiota Modulation, Inflammatory Disorders, and Colorectal Cancer
Vidhya Prakash, Chinchu Bose, Damu Sunilkumar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3370-3370
Open Access | Times Cited: 29

Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It?
Mohamed Salla, Nadine Karaki, Belal El Kaderi, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 569-569
Open Access | Times Cited: 24

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, et al.
Pharmacological Research (2023) Vol. 189, pp. 106679-106679
Open Access | Times Cited: 42

Drug-induced liver injury and anti-hepatotoxic effect of herbal compounds: a metabolic mechanism perspective
Jyoti Rani, Sanju Bala Dhull, Pawan Kumar Rose, et al.
Phytomedicine (2023) Vol. 122, pp. 155142-155142
Closed Access | Times Cited: 33

Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development
Lu Wang, Yonghuan Yan, Linfang Wu, et al.
Pharmacological Research (2023) Vol. 196, pp. 106925-106925
Open Access | Times Cited: 28

SIRT1: Harnessing multiple pathways to hinder NAFLD
Cheng Tian, Rongrong Huang, Ming Xiang
Pharmacological Research (2024) Vol. 203, pp. 107155-107155
Open Access | Times Cited: 13

Optimization of process conditions for ionic liquid-based ultrasound-enzyme-assisted extraction of resveratrol from Polygonum Cuspidatum
Hóngyi Zhào, Junping Wang, Yutong Han, et al.
Ultrasonics Sonochemistry (2024) Vol. 108, pp. 106973-106973
Open Access | Times Cited: 11

Cyclodextrin-based metal-organic frameworks transforming drug delivery
Na Yang, Lingling Wei, Yuou Teng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116546-116546
Closed Access | Times Cited: 9

Hepatoprotective and therapeutic effects of resveratrol: A focus on anti‐inflammatory and antioxidative activities
Supat Chupradit, Dmitry Olegovich Bokov, Mohammad Yasin Zamanian, et al.
Fundamental and Clinical Pharmacology (2021) Vol. 36, Iss. 3, pp. 468-485
Closed Access | Times Cited: 55

The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review
Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi, et al.
Bioinorganic Chemistry and Applications (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 41

Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals
Liang Kang, Huaqing Zhang, Chong-Yu Jia, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34

Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Goh, et al.
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 3, pp. 741-764
Closed Access | Times Cited: 29

Advanced effect of curcumin and resveratrol on mitigating hepatic steatosis in metabolic associated fatty liver disease via the PI3K/AKT/mTOR and HIF-1/VEGF cascade
Yuhui He, Huan Wang, Shiling Lin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115279-115279
Open Access | Times Cited: 18

A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways
Md. Rezaul Islam, Abdur Rauf, Shopnil Alash, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 7

Activation of Nrf2 and FXR via Natural Compounds in Liver Inflammatory Disease
Marta Belka, Aleksandra Gostyńska, Maciej Stawny, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11213-11213
Open Access | Times Cited: 7

Nanoparticles as phytochemical carriers for cancer treatment: News of the last decade
Catarina Melim, Mariana Magalhães, Ana Cláudia Paiva‐Santos, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 2, pp. 179-197
Closed Access | Times Cited: 25

Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma
Tennyson P. Rayginia, Chenicheri K. Keerthana, Sadiq C. Shifana, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 32, pp. 5199-5221
Closed Access | Times Cited: 5

Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Shuangshuang Zhao, Yan Guo, Xunzhe Yin
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 1, pp. 30-30
Open Access | Times Cited: 5

Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects?
Mostafa Vaghari‐Tabari, Forough Alemi, Maryam Zokaei, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 13, pp. 4155-4178
Closed Access | Times Cited: 20

Enhanced Efficacy of Resveratrol Loaded Silver Nanoparticle in Attenuating Sepsis-Induced Acute Liver Injury: Modulation of Inflammation, Oxidative Stress, and SIRT1 Activation
Hilal Üstündağ, Ferdane Danışman Kalındemirtaş, Songül Doğanay, et al.
Shock (2023)
Closed Access | Times Cited: 11

Resveratrol attenuates cyclophosphamide-induced hepatic apoptosis in association with the inhibition of oxidative stress and inflammation in a rat model of acute liver injury
Mohammed A. Alshehri, Mohammed Alissa, Abdullah Alghamdi
Tissue and Cell (2025) Vol. 93, pp. 102728-102728
Closed Access

Binding of the commonly used antioxidants (quercetin, resveratrol, and dihydrolipoic acid) to major circulating proteins – spectroscopic and in silico docking and molecular dynamic simulation studies
Miloš Šunderić, Vladimir Šukalović, Ana Penezić, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-13
Closed Access

Page 1 - Next Page

Scroll to top